Cytokinetics' Myqorzo's trial results, Johnson & Johnson's IBD therapy, and more biotech news from The Readout
Kristoffer Tripplaar/AP
By Elaine Chen
May 5, 2026
National Biotech Reporter
Elaine Chen
Alzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The Readout
A closely watched therapy developed by Johnson & Johnson failed to show a statistically meaningful improvement for IBD patients.
Vivek Ramaswamy wins GOP primary for Ohio governor, CellCentric raises $220M for myeloma drug, and more biotech news
Bristol's partnership with Hengrui Pharma, Viiv loses HIV treatment case, and more biotech news from The Readout
Diamantas takes the reins, Regenxbio stakes claim in Duchenne gene therapy, and more biotech news from The Readout
A Duchenne therapy lawsuit, FDA Commissioner Marty Makary’s White House troubles, and other news from The Readout
